Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity

Journal of Oral and Maxillofacial Surgery - Tập 61 - Trang 774-778 - 2003
Jens J. von Lindern1, Bernd Niederhagen1, Stefaan Bergé1, Thorsten Appel1
1Department of Maxillofacial Surgery, University of Bonn, Bonn, Germany

Tài liệu tham khảo

Franks, 1964, The social character of TMJ dysfunction, Dent Pract, 15, 94 Schwartz, 1957, Temporomandibular joint syndrome, J Prosth Dent, 7, 489, 10.1016/0022-3913(57)90055-0 Nishioka, 1988, Masticatory muscle hyperactivity in temporomandibular disorders, J Am Dent Assoc, 116, 514, 10.14219/jada.archive.1988.0320 Reich, 1988, Erscheinungsformen muskulärer Hyperaktivität im Kiefer und Gesichtsbereich, Dtsch Zahnärztl Z, 43, 11 Brin, 1991, Interventional neurology, Arch Neurobiol, 54, 7 Brin, 1989, Botulinum toxin for the treatment of oromandibulolingual (OMD) dystonia, Neurology, S1, 294 Binz, 1994, Proteolysis of SNAP-25 by types E and A botulinal neurotoxins, J Biol Chem, 169, 1617, 10.1016/S0021-9258(17)42071-0 Giladi, 1997, The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site, J Neurol Sci, 152, 132, 10.1016/S0022-510X(97)00151-2 Aoki, 1998, The development of BOTOX, Pain Digest, 8, 337 Graber, 1985, Was leistet die funktionelle Therapie und wo findet sie ihre Grenzen?, Dtsch Zahnärztl Z, 40, 165 Schulte, 1970, Zur funktionellen Behandlung der Myoarthropathien des Kauorgans Ein diagnostisches und physiotherapeutisches Programm, Dtsch Zahnärztl Z, 25, 422 Childers, 1998, Treatment of painful muscle syndrome with botulinum toxin, J Back Musculoskeletal Rehabil, 10, 89, 10.1016/S1053-8127(98)00007-4 Freund, 1998, The use of botulinum toxin for the treatment of temporomandibular disorder, Oral Health, 2, 32 Freud, 2000, Botulinum toxin, Br J Oral Maxillofac Surg, 38, 466, 10.1054/bjom.1999.0238 Girdler, 1994, Use of botulinum toxin to alleviate facial pain, Br J Hosp Med, 52, 363 Girdler, 1997, Uses of botulinum toxin, Lancet, 349, 953, 10.1016/S0140-6736(05)62730-4 Capra, 1991, Ultrastuctural changes in the masseter muscle of macaca fascicularis resulting from intramuscular injection of botulinum toxin type, A Arch Oral Biol, 36, 827, 10.1016/0003-9969(91)90032-P Filippi, 1993, Botulinum A toxin effect on jaw muscle spindles, Acta Otolaryngol (Stockh), 113, 400, 10.3109/00016489309135834 Guyer, 1999, Mechanism of botulinum toxin in the relief of pain, Curr Rev Pain, 3, 427, 10.1007/s11916-999-0069-y Rosales, 1996, Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection, Muscle Nerv, 19, 488, 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8 Ishikawa, 2000, Presynaptic effects of botulinum toxin type A on the neuronally rabbit iris sphincter and dilator muscles, Jpn J Ophthalmol, 44, 106, 10.1016/S0021-5155(99)00197-5 Benecke, 1975, Effect of type A botulinum toxin on some synaptic transmission in the spinal cord of cats, Pflüglers Arch, 359, 90